Poolbeg Pharma Plc
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0156 USD
−7.24 M USD
0.00 USD
506.98 M
About Poolbeg Pharma PLC
Sector
Industry
CEO
Jeremy Skillington
Website
Headquarters
London
Founded
2021
IPO date
Jul 19, 2021
Identifiers
2
ISIN GB00BKPG7Z60
Poolbeg Pharma Plc is a clinical-stage biopharmaceutical company, which focuses on the development of innovative medicines to address unmet medical needs. The firm's capital light clinical model enables to develop multiple products faster than the traditional biotech model. Its portfolio includes POLB 001, Phase II ready, repositioned small molecule immunomodulatory for severe influenza, along with a vaccine discovery platform, PredictViral biomarker platform, and the disease progression data & bio banks that will be interrogated using AI platforms. The company was founded on March 19, 2021 and is headquartered in London, the United Kingdom.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of POLBF is 0.0661 USD — it has increased by 55.53% in the past 24 hours. Watch Poolbeg Pharma Plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Poolbeg Pharma Plc stocks are traded under the ticker POLBF.
POLBF stock has risen by 55.53% compared to the previous week, the month change is a 55.53% rise, over the last year Poolbeg Pharma Plc has showed a −43.98% decrease.
We've gathered analysts' opinions on Poolbeg Pharma Plc future price: according to them, POLBF price has a max estimate of 0.25 USD and a min estimate of 0.25 USD. Watch POLBF chart and read a more detailed Poolbeg Pharma Plc stock forecast: see what analysts think of Poolbeg Pharma Plc and suggest that you do with its stocks.
POLBF reached its all-time high on May 7, 2024 with the price of 0.2269 USD, and its all-time low was 0.0420 USD and was reached on May 22, 2025. View more price dynamics on POLBF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
POLBF stock is 35.70% volatile and has beta coefficient of 1.73. Track Poolbeg Pharma Plc stock price on the chart and check out the list of the most volatile stocks — is Poolbeg Pharma Plc there?
Today Poolbeg Pharma Plc has the market capitalization of 45.13 M, it has increased by 5.72% over the last week.
Yes, you can track Poolbeg Pharma Plc financials in yearly and quarterly reports right on TradingView.
Poolbeg Pharma Plc is going to release the next earnings report on Feb 26, 2026. Keep track of upcoming events with our Earnings Calendar.
POLBF net income for the last half-year is −2.99 M USD, while the previous report showed −4.42 M USD of net income which accounts for 32.34% change. Track more Poolbeg Pharma Plc financial stats to get the full picture.
No, POLBF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, POLBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Poolbeg Pharma Plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Poolbeg Pharma Plc technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Poolbeg Pharma Plc stock shows the neutral signal. See more of Poolbeg Pharma Plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.